| Patient | Mary Seacole |
|---|---|
| Date of birth | 1805-11-23 |
| Identifiers | MRN HR-NI027-SYN-TD; SSN (made up) 000-27-4483 |
| Document date | 1877-06-15 |
| Author | Adwoa Fairweather-Kent, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Three-month review after chlorthalidone was stopped. [S]
Mary Seacole returns five weeks after the sick visit, when chlorthalidone was stopped for a low sodium. The dizziness on standing went within two days, she ate normally once the cold passed, and she has had no further near-falls. The sodium recheck planned for a week after that visit did not happen: she felt well, and the trip to the laboratory by bus with her knees seemed too much for a single blood test. On amlodipine alone her home readings average 140/82, and her ankles swell a little by evening. She has finished the physical therapy course and goes to the tai chi class twice a week. Her knees are better; she asked about an injection but would rather keep to exercise, her own massage and the gel for now. [S]
| Element | Detail |
|---|---|
| Home readings | Average 140/82 mmHg on amlodipine alone |
| After the sick visit | Dizziness gone; no near-falls; one-week sodium recheck missed |
| Side effects | Mild ankle swelling in the evening |
| Knees | Pain 4 out of 10; tai chi twice a week |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Positive | Mild evening ankle swelling; no dizziness on standing |
| Neurological | Negative | No headaches, confusion, weakness or numbness |
| Musculoskeletal | Positive | Knee pain 4 out of 10 |
| Psychiatric | Negative | Enjoys the tai chi group; mood better |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day | 4 g to each knee up to four times a day | Topical route | 1877-03-09 | active | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1877-03-16 | active | S |
| Chlorthalidone 12.5 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1877-03-16 to 1877-05-11 | completed | S |
| Atorvastatin 20 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1877-04-13 | active | S |
| Losartan 25 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1877-06-15 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1877-06-15 | Body height | 157 | cm | S |
| 1877-06-15 | Body weight | 77.2 | kg | S |
| 1877-06-15 | Body mass index (BMI) [Ratio] | 31.3 | kg/m2 | S |
| 1877-06-15 | Systolic blood pressure | 144 | mm[Hg] | S |
| 1877-06-15 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 1877-06-15 | Heart rate | 74 | /min | S |
| 1877-06-15 | Respiratory rate | 16 | /min | S |
| 1877-06-15 | Body temperature | 36.7 | Cel | S |
| 1877-06-15 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1877-06-15 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 1877-06-15 | Potassium [Moles/volume] in Serum or Plasma | 4.2 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 1877-06-15 | Creatinine [Mass/volume] in Serum or Plasma | 0.94 | mg/dL | 0.59-1.04 mg/dL | Normal | S |
| 1877-06-15 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1872)/1.73 sq M | 65 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 1877-06-15 | Glucose [Mass/volume] in Serum or Plasma | 95 | mg/dL | 70-99 mg/dL | Normal | S |
| 1877-06-15 | Cholesterol [Mass/volume] in Serum or Plasma | 160 | mg/dL | <=199 mg/dL | Normal | S |
| 1877-06-15 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 82 | mg/dL | <=99 mg/dL | Normal | S |
| 1877-06-15 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 56 | mg/dL | >=50 mg/dL | Normal | S |
| 1877-06-15 | Triglyceride [Mass/volume] in Serum or Plasma | 110 | mg/dL | <=149 mg/dL | Normal | S |
| 1877-06-15 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 4 | {score} | S | ||
| 1877-06-15 | Total interval score [KOOSJR] | 61.6 | {score} | S |
Vital signs recorded on 1877-06-15; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 144/84 seated, 140/82 standing at three minutes, pulse 74; weight 77.2 kg |
| Cardiovascular | Regular rhythm; trace ankle edema |
| Musculoskeletal | No knee effusion; Timed Up and Go 13 seconds with the cane |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Headaches on waking for three weeks and blood pressure 184/102 mmHg at the visit (average of two seated readings with a large cuff); no chest pain, breathlessness, visual loss, confusion or weakness; fundi with arteriolar narrowing but no hemorrhages or papilledema; no hypertensive emergency; hypertension not yet confirmed | resolved | provisional | R03.0 | S — Synthetic presenting problem; resolved into stage 2 hypertension when a week of home readings confirmed it. Not a claim about her real health. |
| Stage 2 hypertension confirmed by home readings (seven-day average 168/96 mmHg), with left ventricular hypertrophy by ECG voltage; no albuminuria; 10-year cardiovascular risk about 14%; treated to reduce the risk of stroke, heart failure and kidney disease | active | confirmed | I10 | S — Synthetic modern diagnosis made at the second visit. It is linked to the recorded apoplexy before her death only as the reason for the stroke-prevention teaching; the record does not claim that she had hypertension. |
| Bilateral primary knee osteoarthritis, worse on the left: pain on stairs and on rising from a chair, morning stiffness under 30 minutes, crepitus and bony enlargement without warmth; clinical diagnosis without imaging | active | confirmed | M17.0 | S — Synthetic modern problem; not a claim about her real health. |
| Fall risk: one fall in the past year, a trip on the outside steps without injury; afraid of falling and going out less; STEADI screen positive; Timed Up and Go 15 seconds | active | confirmed | Z91.81 | S — Synthetic fall-risk problem. |
| Obesity, class 1 (BMI 31.6); she calls herself stout and wants to lose some weight for her knees | active | confirmed | E66.811 | S — Synthetic modern problem; her self-description as stout is documented, her weight is not. |
| Thiazide-associated hyponatremia (sodium 129 mmol/L) and hypokalemia (potassium 3.3 mmol/L) with orthostatic hypotension and a near-fall, after four days of a cold with little food while taking chlorthalidone; no confusion; resolved after chlorthalidone was stopped | resolved | confirmed | E87.1 | S — Synthetic adverse drug event at an unscheduled visit; a common effect of thiazide diuretics in older women, not a historical diagnosis. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Blood pressure in the clinic (seated, large cuff, two readings) and at home; target below 130/80 mmHg | Every visit | Completed today | 144/84 mmHg; home average 140/82 |
| Examination | Orthostatic blood pressure (lying and standing) | Every visit | Completed today | No orthostatic drop |
| Examination | Weight and BMI (5% weight-loss goal for knee osteoarthritis) | Every visit | Completed today | 77.2 kg, BMI 31.3 |
| Examination | Cardiac auscultation and edema | Every visit | Completed today | Trace ankle edema from amlodipine |
| Laboratory | Sodium, potassium, creatinine and eGFR | One week after a low sodium, then as for the medicines | Deferred | The sodium and potassium recheck due one week after the sick visit was missed: she felt well, and the bus trip to the laboratory with her knees seemed too much for one test. Today, five weeks after chlorthalidone was stopped, sodium is 138 mmol/L, potassium 4.2 and creatinine 0.94 mg/dL (eGFR 65), all normal, and she has had no symptoms, so no harm resulted. Corrective action: blood tests are drawn at home by the community nurse when a separate trip would be needed |
| Laboratory | Lipid panel | Four to twelve weeks after starting a statin, then yearly | Completed today | Nine weeks on atorvastatin 20 mg: LDL 82 mg/dL (down 44%), total cholesterol 160, HDL 56, triglycerides 110 |
| Imaging | Echocardiogram | At diagnosis if stage 2 or left ventricular hypertrophy | Up to date | Done at the four-week review |
| Survey | Knee pain score (0 to 10) | Every visit | Completed today | 4 out of 10 |
| Survey | Knee function (KOOS JR) | Every visit | Completed today | KOOS JR 61.6 |
| Examination | Knee examination (range of motion, effusion, alignment, crepitus) | Every visit | Completed today | No effusion |
| Self-management | Exercise therapy, tai chi and self-management | Ongoing | Completed today | Physical therapy course finished; tai chi twice a week |
| Medication safety | NSAID safety (topical diclofenac; no oral NSAIDs) | Every visit | Completed today | Diclofenac gel only; intra-articular corticosteroid offered and declined |
| Examination | STEADI assessment: Timed Up and Go, 30-second chair stand, 4-stage balance | At diagnosis of fall risk, then yearly or with a fall | Completed today | Timed Up and Go 13 seconds; one near-fall in May with low sodium, none since |
| Medication safety | Medicine review for fall risk and interactions (Beers criteria) | Every visit | Completed today | Chlorthalidone stopped; losartan added |
| Self-management | Her own remedies: interactions and how she uses them | Every visit | Completed today | Liquorice still paused; ginger tea; liniment on the right knee |
| Self-management | Loneliness, costs and transport | Every visit | Completed today | Tai chi group twice a week; lunch club starting |
Goal progress:
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); Licorice Root (2026); Ginger (2026); CMID: Clinical Monitoring Intelligence Database, hypertension, osteoarthritis and osteoporosis monographs (2026)
Follow-up: Annual wellness visit in four weeks, with potassium and creatinine. Call for dizziness, swelling of the lips or face, or a fall. Next scheduled visit 1877-07-13: subsequent annual wellness visit. [S]